Oligodendroglioma
Etiologia i przyczyny

Oligodendroglioma to rzadki glejak ośrodkowego układu nerwowego, wywodzący się z oligodendrocytów lub ich prekursorów, charakteryzujący się specyficznymi zmianami genetycznymi, w tym kodelecją 1p/19q oraz mutacjami IDH1/IDH2, które stanowią kluczowe markery diagnostyczne i prognostyczne. Kodelecja 1p/19q jest obecna we wszystkich oligodendroglioma i wiąże się z lepszą odpowiedzią na chemioterapię i radioterapię oraz korzystniejszym rokowaniem. Mutacje IDH są wczesnym etapem onkogenezy i korelują z mniej agresywnym przebiegiem choroby. Dodatkowo, mutacje w promotorze TERT oraz genach CIC, FUBP1 i NOTCH1 często współwystępują w tych nowotworach. Etiologia oligodendroglioma jest wieloczynnikowa, obejmująca czynniki genetyczne, epigenetyczne oraz środowiskowe, z udokumentowanym wpływem ekspozycji na promieniowanie jonizujące, zwłaszcza po wcześniejszej radioterapii głowy i szyi.

Etiologia oligodendroglioma – przyczyny i czynniki ryzyka

Oligodendroglioma to rzadki typ nowotworu ośrodkowego układu nerwowego (OUN), który wywodzi się z oligodendrocytów lub ich komórek prekursorowych. Oligodendrocyty to komórki glejowe odpowiedzialne za tworzenie osłonek mielinowych wokół włókien nerwowych w mózgu i rdzeniu kręgowym, które chronią neurony i wspomagają przewodzenie impulsów elektrycznych.123

Dokładna etiologia oligodendroglioma pozostaje w większości przypadków nieznana, jednak badania wykazały, że rozwój tego nowotworu jest prawdopodobnie związany z kombinacją czynników genetycznych, epigenetycznych, komórkowych i środowiskowych.12 Mimo że przyczyny nie zostały w pełni wyjaśnione, zidentyfikowano szereg charakterystycznych zmian genetycznych oraz czynników ryzyka, które mogą przyczyniać się do rozwoju oligodendroglioma.

Zmiany genetyczne w oligodendroglioma

Badania genetyczne wykazały, że oligodendroglioma charakteryzuje się specyficznymi zmianami w materiale genetycznym komórek:12

  • Kodelecja 1p/19q – wszystkie oligodendroglioma mają charakterystyczny defekt genetyczny polegający na jednoczesnej delecji (utracie) krótkiego ramienia chromosomu 1 (1p) i długiego ramienia chromosomu 19 (19q). Ta zmiana jest uważana za marker diagnostyczny oligodendroglioma i określana jako kodelecja 1p/19q.123
  • Mutacje IDH – praktycznie wszystkie oligodendroglioma wykazują mutacje w genach IDH1 lub IDH2 (dehydrogenaza izocytrynianowa). Te mutacje są jednym z pierwszych wydarzeń w procesie onkogenezy i występują powszechnie w różnych podtypach glejaków rozlanych.123
  • Dodatkowe zmiany genetyczne – w oligodendroglioma często występują również mutacje w promotorze genu TERT oraz mutacje genów CIC, FUBP1 i NOTCH1.12

Należy podkreślić, że większość tych zmian genetycznych nie jest dziedziczona, ale powstaje spontanicznie (somatycznie) we wczesnych etapach rozwoju nowotworu.1 Zmiany genetyczne powodują, że komórki nowotworowe otrzymują nieprawidłowe instrukcje dotyczące wzrostu i namnażania. W zdrowych komórkach DNA zawiera instrukcje dotyczące wzrostu i namnażania w określonym tempie oraz informacje o czasie, w którym komórki powinny obumrzeć. W komórkach nowotworowych zmiany DNA prowadzą do szybkiego wzrostu i namnażania, a także uniemożliwiają zaprogramowaną śmierć komórkową (apoptozę), co powoduje nadmierną akumulację komórek tworzących guz.12

Czynniki ryzyka środowiskowe

Chociaż większość przypadków oligodendroglioma występuje sporadycznie, zidentyfikowano kilka czynników środowiskowych, które mogą zwiększać ryzyko rozwoju tego typu nowotworu:12

  • Ekspozycja na promieniowanie jonizujące – narażenie na promieniowanie jonizujące, szczególnie w wyniku wcześniejszej radioterapii głowy i szyi (np. w leczeniu innych nowotworów), jest jednym z najlepiej udokumentowanych czynników ryzyka rozwoju glejaków, w tym oligodendroglioma.1234
  • Ekspozycja na substancje chemiczne – niektóre badania sugerują możliwy związek między ekspozycją na określone toksyny środowiskowe, takie jak pestycydy i metale ciężkie, a zwiększonym ryzykiem rozwoju guzów mózgu, jednak dowody nie są jednoznaczne.12

Mimo pewnych dowodów na wpływ czynników środowiskowych, ich dokładna rola w rozwoju oligodendroglioma wymaga dalszych badań. Wiele badań nad potencjalnymi czynnikami środowiskowymi, takimi jak używanie telefonów komórkowych, narażenie na pola elektromagnetyczne czy sztuczne słodziki (np. aspartam), nie wykazało jednoznacznego związku przyczynowego z rozwojem oligodendroglioma.12

Czynniki genetyczne i rodzinne

Chociaż większość przypadków oligodendroglioma występuje sporadycznie, istnieją pewne czynniki genetyczne i rodzinne, które mogą zwiększać ryzyko jego rozwoju:1

  • Wywiad rodzinny – występowanie guzów mózgu w rodzinie może zwiększać ryzyko rozwoju oligodendroglioma. Badania wykazały, że historia rodzinna guzów mózgu może nawet podwoić ryzyko zachorowania na glejaka, w tym oligodendroglioma.123
  • Zespoły genetyczne – rzadkie zespoły genetyczne, takie jak zespół Neurofibromatosis typu 1 (NF1), zespół Li-Fraumeni czy zespół Turcota, mogą zwiększać ryzyko rozwoju różnych typów guzów mózgu, w tym oligodendroglioma.123

Należy jednak podkreślić, że rodzinne występowanie oligodendroglioma jest rzadkie, a większość przypadków pojawia się sporadycznie, bez wyraźnego związku rodzinnego.12

Czynniki demograficzne i inne

Oprócz czynników genetycznych i środowiskowych, zidentyfikowano również inne potencjalne czynniki ryzyka i zależności epidemiologiczne:1

  • Wiek – oligodendroglioma występuje najczęściej u osób w średnim wieku, ze szczytem zachorowań przypadającym na 4. i 5. dekadę życia. Guzy o wyższym stopniu złośliwości (anaplastyczne oligodendroglioma) mają tendencję do występowania u nieco starszych pacjentów.123
  • Płeć – niektóre dane sugerują nieco większą częstość występowania oligodendroglioma u mężczyzn niż u kobiet, choć różnica ta jest mniej wyraźna niż w przypadku innych pierwotnych guzów mózgu.1
  • Czynniki immunologiczne – badania sugerują, że stany atopowe, takie jak astma, katar sienny czy egzema, mogą mieć działanie ochronne, zmniejszając ryzyko rozwoju anaplastycznego oligodendroglioma.12
  • Przebyte infekcje – niektóre badania wykazały, że przebycie ospy wietrznej może być związane ze zmniejszonym ryzykiem rozwoju oligodendroglioma i anaplastycznego oligodendroglioma.1

Hipotezy patogenetyczne rozwoju oligodendroglioma

Istnieje kilka hipotez dotyczących patogenezy oligodendroglioma:12

Pochodzenie komórek macierzystych i prekursorowych

Jedna z głównych hipotez sugeruje, że oligodendroglioma może powstawać z komórek macierzystych nerwowych lub komórek progenitorowych z prekursorami gleju, które następnie różnicują się w komórki przypominające oligodendrocyty, ale pozbawione zdolności mielinizacyjnych.12 Hipotezę tę wspierają wspólne mutacje inicjujące, szczególnie mutacje IDH, które występują w różnych podtypach glejaków rozlanych i są uznawane za wczesne wydarzenia w procesie onkogenezy.1

Alternatywnie, oligodendroglioma może rozwijać się bezpośrednio z dojrzałych oligodendrocytów. W tym przypadku komórki dojrzałe nabywają mutacje, które prowadzą do transformacji nowotworowej i utraty ich normalnych funkcji.1

Zmiany epigenetyczne

Oprócz zmian genetycznych, w patogenezie oligodendroglioma istotną rolę mogą odgrywać również zmiany epigenetyczne, które wpływają na ekspresję genów bez zmiany sekwencji DNA. Do takich zmian należą modyfikacje histonów, metylacja DNA i regulacja przez niekodujące RNA.1

Hipoteza wirusowa

Niektóre badania sugerują możliwy związek między etiologią oligodendroglioma a czynnikami wirusowymi, jednak dowody nie są jednoznaczne i wymagają dalszych badań.12

Znaczenie kliniczne zmian genetycznych w oligodendroglioma

Charakterystyczne zmiany genetyczne w oligodendroglioma mają nie tylko znaczenie diagnostyczne, ale również prognostyczne i predykcyjne:12

  • Kodelecja 1p/19q – obecność kodelecji 1p/19q jest związana z lepszą odpowiedzią na leczenie (zarówno chemioterapię, jak i radioterapię) oraz korzystniejszym rokowaniem.123
  • Mutacje IDH – obecność mutacji IDH (IDH-mutant) jest związana z mniej agresywnym przebiegiem i dłuższym przeżyciem pacjentów.12

Klasyfikacja WHO nowotworów OUN z 2016 roku, zmodyfikowana w nowszych wydaniach, zrewolucjonizowała diagnozowanie oligodendroglioma, wprowadzając kryteria molekularne. Zgodnie z tą klasyfikacją, oligodendroglioma definiuje się jako guz z mutacją IDH i kodelecją 1p/19q. Guzy dzieli się na dwa stopnie złośliwości: WHO stopień 2 (oligodendroglioma) oraz WHO stopień 3 (anaplastyczne oligodendroglioma).12

Zapobieganie i przyszłe kierunki badań

Ze względu na ograniczoną wiedzę na temat etiologii oligodendroglioma, obecnie nie istnieją skuteczne metody zapobiegania rozwojowi tego nowotworu.12 Głównym kierunkiem badań nad oligodendroglioma jest lepsze zrozumienie jego biologii molekularnej, co może prowadzić do opracowania bardziej skutecznych metod diagnostycznych i terapeutycznych.12

Wyzwaniem w badaniach nad oligodendroglioma jest jego rzadkość, co utrudnia organizację dużych badań klinicznych z wystarczającą liczbą uczestników, aby uzyskać statystycznie istotne wyniki.1 Mimo to, intensywne badania nad genetycznymi i molekularnymi podstawami oligodendroglioma w ostatnich latach przyczyniły się do znacznego postępu w zrozumieniu biologii tego nowotworu, co ma bezpośrednie przełożenie na praktykę kliniczną w zakresie diagnostyki i leczenia.1

Podsumowanie etiologii oligodendroglioma

Oligodendroglioma jest rzadkim nowotworem OUN, którego etiologia nie jest w pełni poznana. Najważniejsze ustalenia dotyczące przyczyn i czynników ryzyka rozwoju oligodendroglioma obejmują:12

  • Charakterystyczne zmiany genetyczne: kodelecja 1p/19q i mutacje IDH1/IDH2 są obecne praktycznie we wszystkich oligodendroglioma i mają kluczowe znaczenie diagnostyczne i prognostyczne.12
  • Ekspozycja na promieniowanie jonizujące, szczególnie w wyniku wcześniejszej radioterapii, jest najbardziej udokumentowanym czynnikiem ryzyka środowiskowego.12
  • Wywiad rodzinny guzów mózgu może zwiększać ryzyko rozwoju oligodendroglioma, choć rodzinne występowanie jest rzadkie.12
  • Rzadkie zespoły genetyczne, takie jak NF1 i zespół Li-Fraumeni, mogą predysponować do rozwoju guzów mózgu, w tym oligodendroglioma.12
  • Czynniki immunologiczne i przebyte infekcje mogą modyfikować ryzyko rozwoju oligodendroglioma.1

Dalsze badania nad etiologią oligodendroglioma są niezbędne, aby lepiej zrozumieć mechanizmy leżące u podstaw rozwoju tego nowotworu i opracować skuteczniejsze strategie diagnostyczne, terapeutyczne i potencjalnie profilaktyczne.12

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Oligodendroglioma: Symptoms, Treatment & Prognosis
    https://my.clevelandclinic.org/health/diseases/21191-oligodendroglioma
    Oligodendrogliomas happen because of two specific DNA changes: […] Oligodendrogliomas always have deletions on the short (p) arm of chromosome 1 and the long (q) arm of chromosome 19. Experts often refer to this as a 1p/19q co-deletion. […] Two IDH mutations, IDH1 or IDH2, can cause oligodendrogliomas. […] Researchers havent confirmed any risk factors for oligodendroglioma. But theres research that could mean past radiation therapy (like the type used to treat other cancers) is a possible factor for developing similar tumors called gliomas. More research is necessary to confirm if that could be a cause or contributing factor.
  • #1 Oligodendroglioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK559184/
    OGs are primary brain tumors originating from oligodendrocytes, the glial cells responsible for myelination in the CNS. […] The etiology of OGs is multifactorial, involving genetic, environmental, epigenetic, and cellular factors. […] The hypothesis that OGs arise either from mature oligodendrocytes or neuroprogenitor cells with glial precursors, which differentiate into oligodendroglial-type cells lacking myelinating capabilities, is supported by shared driver mutations, particularly isocitrate dehydrogenase (IDH) mutations, which are common across various diffuse glioma subtypes and serve as early events in tumorigenesis. […] While specific environmental exposures, such as ionizing radiation or chemicals in certain industries, may play a role, definitive links remain unproven. […] Combining these factors transforms normal oligodendrocytes or their precursors into malignant cells, giving rise to OGs.
  • #1 Oligodendroglioma | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/oligodendroglioma?lang=us
    Oligodendrogliomas are intracranial tumors that account for 5-25% of all gliomas and 5-10% of all primary intracranial neoplasms. […] They are characterized by IDH mutation and 1p19q codeletion and can be WHO CNS grade 2 or 3. […] Oligodendroglioma is considered the third most common glioma accounting for 25% of primary brain tumors and 518% of all glial neoplasms. […] Oligodendrogliomas are usually tumors of middle-aged adults, occurring most commonly in the 4th and 5th decades of life, somewhat older for grade 3 tumors. […] By definition oligodendrogliomas should demonstrate IDH mutation (either IDH1 or IDH2) and 1p19q codeletion. […] Additionally, a number of other mutations are commonly encountered in oligodendrogliomas: TERT promoter mutation, CIC mutation, FUBP1 mutation, NOTCH1 mutations. […] As mentioned earlier response to radiochemotherapy and hence prognosis depends significantly on the presence or absence of 1p19q gene deletion.
  • #1 Oligodendroglioma: Types, Causes, Symptoms, Treatment Strategies, and 2025 Breakthroughs – OncoDaily
    https://oncodaily.com/oncolibrary/cancer-types/oligodendroglioma
    Oligodendroglioma is a rare type of primary brain tumor, and its underlying causes are not fully understood. However, several factors both molecular and demographic have been associated with its development. At the cellular level, virtually all oligodendrogliomas harbor mutations in the IDH1 or IDH2 genes, along with a combined deletion of chromosome arms 1p and 19q. These alterations are not inherited in most patients but occur spontaneously during early tumorigenesis. They are not only diagnostic hallmarks but also contribute to the tumors behavior and responsiveness to treatment. […] In rare cases, genetic cancer predisposition syndromes such as Li-Fraumeni syndrome or Turcot syndrome may increase the risk of gliomas, including oligodendroglioma. However, these inherited conditions are more frequently associated with astrocytic or embryonal tumors and account for only a minority of oligodendroglioma cases. Exposure to ionizing radiation, particularly in childhood, is one of the few environmental risk factors with consistent evidence. Individuals treated with cranial radiation for prior malignancies or benign conditions (such as tinea capitis) may have an increased risk of developing gliomas later in life, including oligodendrogliomas. […] In summary, while molecular alterations define the tumor itself, the risk factors for developing oligodendroglioma are largely non-modifiable and not fully elucidated. Current research continues to explore potential genetic, epigenetic, and environmental contributors to its pathogenesis.
  • #1 Oligodendroglioma | Altru Health System
    https://www.altru.org/health-library/conditions/oligodendroglioma
    The cause of oligodendroglioma often isn’t known. This tumor starts as a growth of cells in the brain or spinal cord. It forms in cells called oligodendrocytes. Oligodendrocytes help protect nerve cells and help with the flow of electrical signals in the brain. […] Oligodendroglioma happens when oligodendrocytes develop changes in their DNA. A cell’s DNA holds the instructions that tell the cell what to do. In healthy cells, the DNA gives instructions to grow and multiply at a set rate. The instructions tell the cells to die at a set time. In tumor cells, the DNA changes give different instructions. The changes tell the tumor cells to grow and multiply quickly. Tumor cells can keep living when healthy cells would die. This causes too many cells. […] The tumor cells form a growth that may press on nearby parts of the brain or spinal cord as the growth gets bigger. Sometimes the DNA changes turn the tumor cells into cancer cells. Cancer cells can invade and destroy healthy body tissue.
  • #1 Oligodendroglioma and Other IDH-Mutated Tumors: Diagnosis and Treatment – NCI
    https://www.cancer.gov/rare-brain-spine-tumor/tumors/oligodendroglioma
    Oligodendrogliomas are commonly found in the white matter and the outer layer of the brain called the cortex. However, they can also form anywhere in the CNS. They are called oligodendrogliomas because their cells resemble oligodendrocytes, a type of brain cell that supports and insulates nerve fibers in the CNS. […] The cause of most oligodendrogliomas is not known. However, exposure to radiation and certain gene changes that can be passed down through families have been linked to a higher chance of developing oligodendrogliomas.
  • #1 Oligodendroglioma | Brain Tumor Center | Stanford Medicine
    https://med.stanford.edu/brain-tumor/conditions/glioma/oligodendroglioma.html
    Oligodendrogliomas are tumors that arise within the central nervous system. […] Most oligodendrogliomas occur in people without risk factors. […] People who have had radiation therapy (ionizing radiation) to treat cancer have an increased risk of developing glioma, especially those who received radiation treatment to their head and neck during childhood. […] Oligodendroglioma rarely runs in families, but some diagnosed cases may have a genetic component. […] Some inherited gene variants have been associated with a small increased risk of oligodendroglioma. Inheriting one of these „risk variants” does not necessarily mean the person will develop glioma. Additional mutations are still required to lead to tumor formation. […] The presence of specific genetic markers (mutations) has been shown to be a reliable predictor of tumor behavior and treatment response.
  • #1 „Oligodendroglioma: Causes, Symptoms, Treatment Options, and Prevention Strategies”
    https://www.doctorshubnepal.com/diseases-conditions/oligodendroglioma
    Oligodendroglioma is a rare and complex brain tumor that originates from the oligodendrocytes, cells that produce myelin, a fatty substance that protects nerve cells and facilitates the transmission of electrical signals in the brain and spinal cord. […] The exact cause of oligodendroglioma is not fully understood, but it is believed to be related to a combination of genetic and environmental factors. Some possible risk factors include: […] Genetic mutations in genes such as NF2 and SMARCB1 have been linked to an increased risk of developing oligodendroglioma. […] Exposure to certain environmental toxins, such as pesticides and heavy metals, may increase the risk of developing oligodendroglioma. […] Having a family history of brain tumors or other types of cancer may increase the risk of developing oligodendroglioma.
  • #1 Oligodendroglioma – Conditions – Neurooncology – Specialties – UR Neurosurgery – University of Rochester Medical Center
    https://www.urmc.rochester.edu/cancer-institute/cancers/brain-spine/multidisciplinary-care/neurosurgery/tumor-types/oligodendroglioma
    Oligodendrogliomas are brain tumors that come from a type of brain cell known as an oligodendrocyte. […] No one knows for sure what causes oligodendrogliomas, although exposure to radiation may increase the likelihood of developing a brain tumor. […] While scientists have looked at other possible causes such as aspartame (Nutrasweet), cell phones, and power lines, no one has been able to show that any of these clearly cause oligodendrogliomas.
  • #1 Oligodendroglioma – Symptoms, Diagnosis, TreatmentSecond Opinion IconGroup 9Second Opinion IconGroup 49
    https://www.barrowneuro.org/condition/oligodendroglioma/
    Most oligodendrogliomas are not inherited, but a family history of brain tumors or gliomas can slightly increase the overall risk. The risk is still low, as oligodendrogliomas usually occur sporadically without a strong familial link. […] Currently, there is no known way to prevent oligodendrogliomas from developing. They are sporadic tumors, meaning they tend to occur without clear, preventable risk factors. […] Some cases are linked to rare genetic conditions, like neurofibromatosis type I (NF1) and Li-Fraumeni Syndrome, which increases the risk of some brain tumors, including oligodendrogliomas.
  • #1 Risk factors for oligodendroglial tumors: A pooled international study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3064625/
    Oligodendroglial tumors are rare subtypes of brain tumors and are often combined with other glial tumors in epidemiological analyses. However, different demographic associations and clinical characteristics suggest potentially different risk factors. […] The purpose of this study was to investigate possible risk factors for oligodendroglial tumors (including oligodendroglioma, anaplastic oligodendroglioma, and mixed glioma). […] A family history of brain tumors was associated with an increased risk of anaplastic oligodendroglioma (OR = 2.2; 95% CI: 1.14.5). […] Although there is some overlap in risk factors between oligodendroglial tumors and gliomas as a group, it is likely that additional factors specific to oligodendroglial tumors have yet to be identified. […] Factors previously found to be associated with the larger category of glioma (which includes oligodendroglial tumors), such as ionizing radiation, family history of brain tumors, and allergic disease, may also be specifically associated with oligodendroglial tumors.
  • #1 Understanding Oligodendroglioma: A Comprehensive Guide – BeatCancer
    https://beatcancer.eu/oligodendroglioma/
    Oligodendrogliomas are brain tumors that originate from oligodendrocytes, which are a type of glial cell that forms the myelin sheath around nerve fibers. […] Although the exact cause of oligodendrogliomas remains unknown, research has identified certain genetic abnormalities that frequently manifest in these tumors, suggesting a genetic predisposition. […] Studies to determine the influence of environmental factors on oligodendroglioma continue, yet no definitive correlations have been confirmed. This ongoing research considers potential influences including exposure to radiation and organic solvents. […] Oligodendrogliomas are more common among adults aged between 40 and 50. While the incidence is slightly higher in males than females, this gender disparity is less pronounced compared to other types of primary brain tumors.
  • #1 Risk factors for oligodendroglial tumors: A pooled international study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3064625/
    The risk of anaplastic oligodendroglioma was increased in those with a family history of any brain tumor (OR = 2.2; 95% CI: 1.14.5). […] Asthma and/or allergies were associated with a decreased risk of anaplastic oligodendroglioma (OR = 0.6; 95% CI: 0.40.9) and with a borderline significantly reduced risk for mixed glioma (OR = 0.6; 95% CI: 0.31.0) but were not statistically significantly associated with oligodendroglioma (OR = 0.9; 95% CI: 0.61.2). […] Having had chicken pox was associated with a decreased risk of oligodendroglioma (OR = 0.6; 95% CI: 0.40.9) and anaplastic oligodendroglioma (OR = 0.5; 95% CI: 0.30.9). […] It is likely, however, that there are other risk factors yet to be identified specific to oligodendroglial tumors.
  • #1 Oligodendroglioma causes – wikidoc
    https://www.wikidoc.org/index.php/Oligodendroglioma_causes
    The most common etiology of oligodendroglioma includes genetic mutations such as t(1;19)(q10;p10), NJDS, IDH1, IDH2, CIC, FUBP1, p53, Leu-7, TCF-12, MGMT, TP73, EGFR and PTEN. It may be associated with some viral cause or irradiation of pituitary adenoma. […] The most common etiology of oligodendroglioma includes mutations in the following genes: t(1;19)(q10;p10), NJDS (A 2009 Oxford Neurosymposium study illustrated that there’s a 69% correlation between NJDS gene mutation and tumor initiation), IDH1, IDH2, CIC, FUBP1, p53, Leu-7, TCF-12, MGMT, TP73, EGFR, PTEN. […] It may be associated with some viral cause. […] A single case report linked oligodendroglioma to the irradiation of pituitary adenoma.
  • #1 Oligodendroglioma | Brain Tumor Center | Stanford Medicine
    https://med.stanford.edu/brain-tumor/conditions/glioma/oligodendroglioma.html
    Isocitrate dehydrogenase (IDH) mutation In general, oligodendromas have this mutation. When this biomarker is present (IDH-mutant), the tumor is not as aggressive, and patients tend to live longer. […] Codeletion (loss) of chromosomal arms 1p and 19q All oligodendrogliomas have this mutation. This biomarker mutation causes the tumor to have better prognosis than other glioma types. […] Grading is a prediction of how the cancer would behave without treatment. Grade 2 oligodendrogliomas grow more slowly while grade 3 tumors grow more rapidly and can spread within the brain and spinal cord.
  • #1 Oligodendrogliomas Diagnosis & Treatment – NYC | Columbia Neurosurgery in New York City
    https://www.neurosurgery.columbia.edu/patient-care/conditions/oligodendrogliomas
    Oligodendrogliomas are tumors that develop from a certain type of cell called oligodendroglial progenitor cells. […] As is the case with most brain tumors, the cause of oligodendroglioma is unknown. […] However, some oligodendrogliomas have recognizable chromosomal abnormalities that seem to play a role in the disease progression. […] Deletion of the p arm on chromosome 1 (1p deletion) and/or deletion of the q arm on chromosome 19 (19q deletion) may indicate that the response to treatment will be better than for tumors without these characteristics. […] Oligodendrogliomas can also have a mutation in the gene IDH1, in which case they have a more favorable prognosis. […] In general, oligodendrogliomas have a better prognosis and better response to therapies than other infiltrative gliomas.
  • #1 Oligodendroglioma – American Brain Tumor Association | Learn More
    https://www.abta.org/tumor_types/oligodendroglioma/
    Oligodendrogliomas come from oligodendrocytes, one of the types of cells that make up the supportive, or glial, tissue of the brain. […] Although all tumors (including oligodendroglioma) are caused by genetic changes, the exact cause of most oligodendrogliomas is not known. Exposure to radiation and certain gene changes that can be passed down through families have been linked to a higher chance of developing oligodendrogliomas. […] Oligodendrogliomas are a type of glioma that have mutations in one of two genes called IDH1 and IDH2 and are missing the two chromosomal arms, 1p and 19q. These tumors are thus named Oligodendroglioma, IDH-mutant, and 1p/19q-codeleted.
  • #1 Oligodendroglioma – Symptoms, Diagnosis, TreatmentSecond Opinion IconGroup 9Second Opinion IconGroup 49
    https://www.barrowneuro.org/condition/oligodendroglioma/
    Oligodendrogliomas are a type of glioma and tend to grow slowly, often over many years. […] Like many other types of tumors, the exact cause of oligodendrogliomas is unknown. Most appear to develop sporadically, meaning they happen by chance, without an inherited or environmental cause. […] That said, there is a combination of genetic changes and, in some cases, environmental factors that can play a role in their development. […] Many oligodendrogliomas have mutations in the IDH1 or IDH2 gene. Another hallmark is a genetic change called the 1p/19q codeletion, where certain sections of chromosomes 1 and 19 are missing. […] Although rare, high-dose ionizing radiation—for example, from radiation therapy for another cancer—has been linked to an increased risk of brain tumors, but this typically occurs only in those who have received radiation to the head.
  • #1 Oligodendroglioma in Children and Teens – Together by St. Jude™
    https://together.stjude.org/en-us/conditions/cancers/oligodendroglioma.html
    The cause of oligodendroglioma is unknown. But certain genetic changes in cells are linked to these tumors. […] Doctors are learning more about molecular changes and gene mutations (DNA changes) that occur in the cells of the tumor. Most oligodendrogliomas have a molecular marker that helps in the diagnosis. But oligodendrogliomas in young children may not have these molecular features. In these cases, doctors use imaging tests, pathology, and clinical features to make a diagnosis. Understanding changes in tumor cells can help doctors plan treatments and develop better therapies in the future.
  • #1 Oligodendroglioma: Life Expectancy, Survival Rates, and Treatment
    https://www.healthline.com/health/oligodendroglioma
    There are no known causes of oligodendroglioma. Research that is focused around genetics is currently underway, but this has not been completed. Unfortunately, there are fewer clinical trials for rare forms of cancer because they are harder to organize. […] When a research trial is too small, the results arent strong enough to prove that one type of treatment is better than another. So, getting enough people to participate is crucial to the success of a trial.
  • #1 Oligodendroglioma | The Brain Tumour Charity
    https://www.thebraintumourcharity.org/brain-tumour-diagnosis-treatment/types-of-brain-tumour-adult/oligodendroglioma/
    Oligodendrogliomas account for roughly 3% of all primary brain tumours. […] As with most tumours, the exact cause of oligodendrogliomas is not known, although we do understand some of the risk factors. […] The Brain Tumour Charity is contributing to the funding of research into the possible causes of brain tumour development as we accelerate towards a cure.
  • #2 Oligodendroglioma | Altru Health System
    https://www.altru.org/health-library/conditions/oligodendroglioma
    The cause of oligodendroglioma often isn’t known. This tumor starts as a growth of cells in the brain or spinal cord. It forms in cells called oligodendrocytes. Oligodendrocytes help protect nerve cells and help with the flow of electrical signals in the brain. […] Oligodendroglioma happens when oligodendrocytes develop changes in their DNA. A cell’s DNA holds the instructions that tell the cell what to do. In healthy cells, the DNA gives instructions to grow and multiply at a set rate. The instructions tell the cells to die at a set time. In tumor cells, the DNA changes give different instructions. The changes tell the tumor cells to grow and multiply quickly. Tumor cells can keep living when healthy cells would die. This causes too many cells. […] The tumor cells form a growth that may press on nearby parts of the brain or spinal cord as the growth gets bigger. Sometimes the DNA changes turn the tumor cells into cancer cells. Cancer cells can invade and destroy healthy body tissue.
  • #2 Oligodendroglioma: Types, Causes, Symptoms, Treatment Strategies, and 2025 Breakthroughs – OncoDaily
    https://oncodaily.com/oncolibrary/cancer-types/oligodendroglioma
    Oligodendroglioma is a rare type of primary brain tumor, and its underlying causes are not fully understood. However, several factors both molecular and demographic have been associated with its development. At the cellular level, virtually all oligodendrogliomas harbor mutations in the IDH1 or IDH2 genes, along with a combined deletion of chromosome arms 1p and 19q. These alterations are not inherited in most patients but occur spontaneously during early tumorigenesis. They are not only diagnostic hallmarks but also contribute to the tumors behavior and responsiveness to treatment. […] In rare cases, genetic cancer predisposition syndromes such as Li-Fraumeni syndrome or Turcot syndrome may increase the risk of gliomas, including oligodendroglioma. However, these inherited conditions are more frequently associated with astrocytic or embryonal tumors and account for only a minority of oligodendroglioma cases. Exposure to ionizing radiation, particularly in childhood, is one of the few environmental risk factors with consistent evidence. Individuals treated with cranial radiation for prior malignancies or benign conditions (such as tinea capitis) may have an increased risk of developing gliomas later in life, including oligodendrogliomas. […] In summary, while molecular alterations define the tumor itself, the risk factors for developing oligodendroglioma are largely non-modifiable and not fully elucidated. Current research continues to explore potential genetic, epigenetic, and environmental contributors to its pathogenesis.
  • #2 Oligodendrogliomas Diagnosis & Treatment – NYC | Columbia Neurosurgery in New York City
    https://www.neurosurgery.columbia.edu/patient-care/conditions/oligodendrogliomas
    Oligodendrogliomas are tumors that develop from a certain type of cell called oligodendroglial progenitor cells. […] As is the case with most brain tumors, the cause of oligodendroglioma is unknown. […] However, some oligodendrogliomas have recognizable chromosomal abnormalities that seem to play a role in the disease progression. […] Deletion of the p arm on chromosome 1 (1p deletion) and/or deletion of the q arm on chromosome 19 (19q deletion) may indicate that the response to treatment will be better than for tumors without these characteristics. […] Oligodendrogliomas can also have a mutation in the gene IDH1, in which case they have a more favorable prognosis. […] In general, oligodendrogliomas have a better prognosis and better response to therapies than other infiltrative gliomas.
  • #2 Oligodendroglioma | Brain Tumor Center | Stanford Medicine
    https://med.stanford.edu/brain-tumor/conditions/glioma/oligodendroglioma.html
    Isocitrate dehydrogenase (IDH) mutation In general, oligodendromas have this mutation. When this biomarker is present (IDH-mutant), the tumor is not as aggressive, and patients tend to live longer. […] Codeletion (loss) of chromosomal arms 1p and 19q All oligodendrogliomas have this mutation. This biomarker mutation causes the tumor to have better prognosis than other glioma types. […] Grading is a prediction of how the cancer would behave without treatment. Grade 2 oligodendrogliomas grow more slowly while grade 3 tumors grow more rapidly and can spread within the brain and spinal cord.
  • #2 Oligodendroglioma causes – wikidoc
    https://www.wikidoc.org/index.php/Oligodendroglioma_causes
    The most common etiology of oligodendroglioma includes genetic mutations such as t(1;19)(q10;p10), NJDS, IDH1, IDH2, CIC, FUBP1, p53, Leu-7, TCF-12, MGMT, TP73, EGFR and PTEN. It may be associated with some viral cause or irradiation of pituitary adenoma. […] The most common etiology of oligodendroglioma includes mutations in the following genes: t(1;19)(q10;p10), NJDS (A 2009 Oxford Neurosymposium study illustrated that there’s a 69% correlation between NJDS gene mutation and tumor initiation), IDH1, IDH2, CIC, FUBP1, p53, Leu-7, TCF-12, MGMT, TP73, EGFR, PTEN. […] It may be associated with some viral cause. […] A single case report linked oligodendroglioma to the irradiation of pituitary adenoma.
  • #2
    https://braintumourresearch.org/pages/types-of-brain-tumours-oligodendroglioma?srsltid=AfmBOopJTxTuX_1XvGXygYGYr2aYD4_msPewo4AKpZDPDpef9ZEvtkNc
    Oligodendroglioma, sometimes referred to as an oligodendroglial tumour, is a rare, usually slow-growing tumour that forms from oligodendrocytes, which are a form of glial cell. […] A glioma brain tumour develops from cells that begin as neural stem cells. From this state they become progenitor cells, and then glial cells. When glial cells form a glioma tumour, damage can be seen in the DNA and they no longer undergo apoptosis, which means programmed or purposeful cell death. Apoptosis is an important process that enables our bodies to destroy cells that are faulty or at the end of their natural life cycle. When this process fails to happen, cells grow in an uncontrolled way and build up to form a tumour.
  • #2 Oligodendroglioma – Symptoms, Diagnosis, TreatmentSecond Opinion IconGroup 9Second Opinion IconGroup 49
    https://www.barrowneuro.org/condition/oligodendroglioma/
    Oligodendrogliomas are a type of glioma and tend to grow slowly, often over many years. […] Like many other types of tumors, the exact cause of oligodendrogliomas is unknown. Most appear to develop sporadically, meaning they happen by chance, without an inherited or environmental cause. […] That said, there is a combination of genetic changes and, in some cases, environmental factors that can play a role in their development. […] Many oligodendrogliomas have mutations in the IDH1 or IDH2 gene. Another hallmark is a genetic change called the 1p/19q codeletion, where certain sections of chromosomes 1 and 19 are missing. […] Although rare, high-dose ionizing radiation—for example, from radiation therapy for another cancer—has been linked to an increased risk of brain tumors, but this typically occurs only in those who have received radiation to the head.
  • #2 Oligodendroglioma – Symptoms, Types, Causes & Diagnosis
    https://www.ganeshdiagnostic.com/blog/oligodendroglioma-symptoms-types-causes-and-diagnosis
    Oligodendrocytes are the source of oligodendrogliomas. […] There are a few risk factors for oligodendroglioma, yet the reason is still unknown: […] Although brain tumours can develop at any age, the danger increases with ageing. […] Nuclear weapons exposure and radiation therapy used to treat cancer are two examples of ionising radiation. […] Although a genetic component is uncommon, a family history of glioma might increase a person’s risk by twofold. […] Gene alterations that affect how cells function can result in cancer. […] Normal genes may become cancer-causing genes as a result of mutations. […] Certain environmental and lifestyle factors, such as exposure to chemicals, smoking, and food, can result in mutations. […] Oligodendroglioma is uncommon. […] Although it is rare, oligodendrogliomas can spread to other parts of the CNS through the cerebrospinal fluid (CSF).
  • #2 Glioblastoma: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/283252-overview
    The etiology of glioblastoma remains unknown in most cases. Suggested causes include the following: […] The only established non-genetic risk factor for glioblastoma is ionizing radiation to the head or neck. […] Although concerns have been raised regarding cell phone use as a potential risk factor for development of gliomas, study results have been inconsistent, and this possibility remains controversial. […] Studies of association with head injury, N-nitroso compounds, occupational hazards, and electromagnetic field exposure have been inconclusive. […] There is a growing consensus that atopic conditions, including asthma, hay fever, eczema, and food allergies, are protective, reducing the risk of various forms of glioma including glioblastoma by nearly 40%.
  • #2 Oligodendroglioma Treatment -New Jersey – Centers for Neurosurgery, Spine & Orthopedics
    https://www.cnsomd.com/surgery-conditions/brain-tumors/oligodendroglioma/
    Scientists have yet to determine what causes an oligodendroglioma to form and exactly what genetic mutation increases the likelihood. […] Some of the risk factors identified in the development of an oligodendroglioma include: Age: The risk of developing the tumor increases with age. An oligodendroglioma is more common in adults aged 40 to 60 years old. However, it can occur in any age. […] Exposure to radiation: People exposed to ionizing radiation have an increased risk of tumors. Nearly 1% of brain tumors are thought to be caused by ionizing radiation. […] Family history: Although it is rare for the oligodendroglioma to run in families, having a family history of the tumor may double the risk for family members.
  • #2 Oligodendroglioma | Boston Children’s Hospital
    https://www.childrenshospital.org/conditions/oligodendroglioma
    Oligodendrogliomas are low-grade gliomas, a type of brain tumor, that arise from a type of cell called an oligodendrocyte. […] Certain genetic syndromes, such as neurofibromatosis 1 and tuberous sclerosis, increase the risk for developing brain tumors, including oligodendrogliomas. However, most of these tumors develop spontaneously for no known reason. […] The vast majority of children with oligodendrogliomas develop them spontaneously, and there is no identifiable cause. However, if your child has certain genetic syndromes, including neurofibromatosis type I and tuberous sclerosis, he may be at a higher risk of developing certain kinds of tumors, including oligodendrogliomas.
  • #2 Oligodendroglioma | Brain Tumor Center | Stanford Medicine
    https://med.stanford.edu/brain-tumor/conditions/glioma/oligodendroglioma.html
    Oligodendrogliomas are tumors that arise within the central nervous system. […] Most oligodendrogliomas occur in people without risk factors. […] People who have had radiation therapy (ionizing radiation) to treat cancer have an increased risk of developing glioma, especially those who received radiation treatment to their head and neck during childhood. […] Oligodendroglioma rarely runs in families, but some diagnosed cases may have a genetic component. […] Some inherited gene variants have been associated with a small increased risk of oligodendroglioma. Inheriting one of these „risk variants” does not necessarily mean the person will develop glioma. Additional mutations are still required to lead to tumor formation. […] The presence of specific genetic markers (mutations) has been shown to be a reliable predictor of tumor behavior and treatment response.
  • #2 Oligodendroglioma: Symptoms, causes, and treatment
    https://www.medicalnewstoday.com/articles/oligodendroglioma
    Oligodendroglioma may arise in cells in the brain known as oligodendrocytes. These cells produce the protective sheath that surrounds nerves in the brain and spinal cord. […] The exact cause of oligodendroglioma is uncertain, but several factors may increase the risk, including: […] Changes in specific genes, such as the IDH1 or IDH2 genes, have links to oligodendrogliomas. […] People with family members with brain tumors or certain genetic syndromes may have an increased risk of oligodendroglioma. […] Previous exposure to ionizing radiation, especially to the head, may elevate the risk of developing brain tumors. […] Doctors diagnose oligodendrogliomas more commonly in adults ages between 30 and 40 years. There is also a smaller peak of occurrences in children ages 6 to 12 years.
  • #2 Oligodendroglioma – MD Searchlight
    https://mdsearchlight.com/cancer/oligodendroglioma/
    Oligodendroglioma (OG) is a kind of brain tumor that makes up about 5% of all primary brain tumors. […] It is not entirely clear how Oligodendrogliomas (OGs) are formed, but current thinking suggests that they may come from early nerve cells (neuroprogenitor cells) with markers of glial cells. These early nerve cells then change into OGs, but they do not have the ability to produce myelin like oligodendrocytes. […] Supporting this idea, a common genetic mutation called isocitrate dehydrogenase (IDH) has been found in various types of brain tumors including OGs. This hints that similar processes underlie these different tumor types.
  • #2 Oligodendroglioma – Wikipedia
    https://en.wikipedia.org/wiki/Oligodendroglioma
    Oligodendrogliomas are a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell. […] The cause of oligodendrogliomas is unknown. Some studies have linked oligodendroglioma with a viral cause. A 2009 Oxford Neurosymposium study illustrated a 69% correlation between NJDS gene mutation and the tumor initiation. […] A single case report has linked oligodendroglioma to irradiation of pituitary adenoma.
  • #2 Oligodendroghoma | North Bristol NHS Trust
    https://www.nbt.nhs.uk/bnog/bnog-treatments/oligodendroghoma
    No causes or risk factors are known. […] Occasional clustering occurs in some families, although the mode of inheritance is unknown. […] Patients with anaplastic oligodendrogliomas (WHO grade 3) who have loss of heterozygosity on 1p or combined loss of heterozygosity on 1p and 19q survive substantially longer than patients whose tumours lack these genetic changes.
  • #2 Oligodendroglioma | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/oligodendroglioma?lang=us
    Oligodendrogliomas are intracranial tumors that account for 5-25% of all gliomas and 5-10% of all primary intracranial neoplasms. […] They are characterized by IDH mutation and 1p19q codeletion and can be WHO CNS grade 2 or 3. […] Oligodendroglioma is considered the third most common glioma accounting for 25% of primary brain tumors and 518% of all glial neoplasms. […] Oligodendrogliomas are usually tumors of middle-aged adults, occurring most commonly in the 4th and 5th decades of life, somewhat older for grade 3 tumors. […] By definition oligodendrogliomas should demonstrate IDH mutation (either IDH1 or IDH2) and 1p19q codeletion. […] Additionally, a number of other mutations are commonly encountered in oligodendrogliomas: TERT promoter mutation, CIC mutation, FUBP1 mutation, NOTCH1 mutations. […] As mentioned earlier response to radiochemotherapy and hence prognosis depends significantly on the presence or absence of 1p19q gene deletion.
  • #2 Oligodendroglioma Signs & Treatment | Baptist Health
    https://www.baptisthealth.com/care-services/conditions-treatments/oligodenroglioma
    The cause of oligodendrogliomas is unknown. […] There is no known way to prevent oligodendrogliomas.
  • #2 Glioma: Astrocytoma, Glioblastoma, Oligodendroglioma, and Other Types of Gliomas | Memorial Sloan Kettering Cancer Center
    https://www.mskcc.org/cancer-care/types/glioma/types-glioma
    Oligodendroglioma starts in the glial cells called oligodendrocytes. These cells cover and protect nerve cells in the brain and spinal cord. This is kind of glioma grows slowly and is less common. […] Oligodendrogliomas have an IDH mutation. MSK is studying new treatments for tumors, including oligodendrogliomas, that have this mutation.
  • #2 Oligodendroglioma in Children and Teens – Together by St. Jude™
    https://together.stjude.org/en-us/conditions/cancers/oligodendroglioma.html
    The cause of oligodendroglioma is unknown. But certain genetic changes in cells are linked to these tumors. […] Doctors are learning more about molecular changes and gene mutations (DNA changes) that occur in the cells of the tumor. Most oligodendrogliomas have a molecular marker that helps in the diagnosis. But oligodendrogliomas in young children may not have these molecular features. In these cases, doctors use imaging tests, pathology, and clinical features to make a diagnosis. Understanding changes in tumor cells can help doctors plan treatments and develop better therapies in the future.
  • #3 Oligodendroglioma – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK559184/
    OGs are primary brain tumors originating from oligodendrocytes, the glial cells responsible for myelination in the CNS. […] The etiology of OGs is multifactorial, involving genetic, environmental, epigenetic, and cellular factors. […] The hypothesis that OGs arise either from mature oligodendrocytes or neuroprogenitor cells with glial precursors, which differentiate into oligodendroglial-type cells lacking myelinating capabilities, is supported by shared driver mutations, particularly isocitrate dehydrogenase (IDH) mutations, which are common across various diffuse glioma subtypes and serve as early events in tumorigenesis. […] While specific environmental exposures, such as ionizing radiation or chemicals in certain industries, may play a role, definitive links remain unproven. […] Combining these factors transforms normal oligodendrocytes or their precursors into malignant cells, giving rise to OGs.
  • #3 Oligodendroglioma – American Brain Tumor Association | Learn More
    https://www.abta.org/tumor_types/oligodendroglioma/
    Oligodendrogliomas come from oligodendrocytes, one of the types of cells that make up the supportive, or glial, tissue of the brain. […] Although all tumors (including oligodendroglioma) are caused by genetic changes, the exact cause of most oligodendrogliomas is not known. Exposure to radiation and certain gene changes that can be passed down through families have been linked to a higher chance of developing oligodendrogliomas. […] Oligodendrogliomas are a type of glioma that have mutations in one of two genes called IDH1 and IDH2 and are missing the two chromosomal arms, 1p and 19q. These tumors are thus named Oligodendroglioma, IDH-mutant, and 1p/19q-codeleted.
  • #3 Risk factors for oligodendroglial tumors: A pooled international study
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3064625/
    Oligodendroglial tumors are rare subtypes of brain tumors and are often combined with other glial tumors in epidemiological analyses. However, different demographic associations and clinical characteristics suggest potentially different risk factors. […] The purpose of this study was to investigate possible risk factors for oligodendroglial tumors (including oligodendroglioma, anaplastic oligodendroglioma, and mixed glioma). […] A family history of brain tumors was associated with an increased risk of anaplastic oligodendroglioma (OR = 2.2; 95% CI: 1.14.5). […] Although there is some overlap in risk factors between oligodendroglial tumors and gliomas as a group, it is likely that additional factors specific to oligodendroglial tumors have yet to be identified. […] Factors previously found to be associated with the larger category of glioma (which includes oligodendroglial tumors), such as ionizing radiation, family history of brain tumors, and allergic disease, may also be specifically associated with oligodendroglial tumors.
  • #3 Oligodendroglioma | Expert Surgeon | Aaron Cohen-Gadol, MD
    https://www.aaroncohen-gadol.com/en/patients/glioma/types/oligodendroglioma
    Oligodendroglioma is believed to be caused by abnormal genes within the tumor cells. […] It is not clear how these abnormalities arise, although ionizing radiation has been implicated. […] A family history of oligodendroglioma can double the risk of a diagnosis.
  • #3 Oligodendroglioma: Types, Causes, Symptoms, Treatment Strategies, and 2025 Breakthroughs – OncoDaily
    https://oncodaily.com/oncolibrary/cancer-types/oligodendroglioma
    Oligodendroglioma is a rare type of primary brain tumor, and its underlying causes are not fully understood. However, several factors both molecular and demographic have been associated with its development. At the cellular level, virtually all oligodendrogliomas harbor mutations in the IDH1 or IDH2 genes, along with a combined deletion of chromosome arms 1p and 19q. These alterations are not inherited in most patients but occur spontaneously during early tumorigenesis. They are not only diagnostic hallmarks but also contribute to the tumors behavior and responsiveness to treatment. […] In rare cases, genetic cancer predisposition syndromes such as Li-Fraumeni syndrome or Turcot syndrome may increase the risk of gliomas, including oligodendroglioma. However, these inherited conditions are more frequently associated with astrocytic or embryonal tumors and account for only a minority of oligodendroglioma cases. Exposure to ionizing radiation, particularly in childhood, is one of the few environmental risk factors with consistent evidence. Individuals treated with cranial radiation for prior malignancies or benign conditions (such as tinea capitis) may have an increased risk of developing gliomas later in life, including oligodendrogliomas. […] In summary, while molecular alterations define the tumor itself, the risk factors for developing oligodendroglioma are largely non-modifiable and not fully elucidated. Current research continues to explore potential genetic, epigenetic, and environmental contributors to its pathogenesis.
  • #3 Oligodendroglioma | UTHealth Neurosciences
    https://med.uth.edu/neurosciences/oligodendroglioma/
    The cause of these tumors is unknown. Radiation exposure and certain genetic changes have been linked to higher occurrences of oligodendrogliomas. […] People with family members with glioma have a higher chance of developing oligodendroglioma. […] Patients are typically diagnosed after age 45.
  • #3 Oligodendroglioma | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/oligodendroglioma?lang=us
    Oligodendrogliomas are intracranial tumors that account for 5-25% of all gliomas and 5-10% of all primary intracranial neoplasms. […] They are characterized by IDH mutation and 1p19q codeletion and can be WHO CNS grade 2 or 3. […] Oligodendroglioma is considered the third most common glioma accounting for 25% of primary brain tumors and 518% of all glial neoplasms. […] Oligodendrogliomas are usually tumors of middle-aged adults, occurring most commonly in the 4th and 5th decades of life, somewhat older for grade 3 tumors. […] By definition oligodendrogliomas should demonstrate IDH mutation (either IDH1 or IDH2) and 1p19q codeletion. […] Additionally, a number of other mutations are commonly encountered in oligodendrogliomas: TERT promoter mutation, CIC mutation, FUBP1 mutation, NOTCH1 mutations. […] As mentioned earlier response to radiochemotherapy and hence prognosis depends significantly on the presence or absence of 1p19q gene deletion.
  • #4 Oligodendroglioma: Types, Causes, Symptoms, Treatment Strategies, and 2025 Breakthroughs – OncoDaily
    https://oncodaily.com/oncolibrary/cancer-types/oligodendroglioma
    Oligodendroglioma is a rare type of primary brain tumor, and its underlying causes are not fully understood. However, several factors both molecular and demographic have been associated with its development. At the cellular level, virtually all oligodendrogliomas harbor mutations in the IDH1 or IDH2 genes, along with a combined deletion of chromosome arms 1p and 19q. These alterations are not inherited in most patients but occur spontaneously during early tumorigenesis. They are not only diagnostic hallmarks but also contribute to the tumors behavior and responsiveness to treatment. […] In rare cases, genetic cancer predisposition syndromes such as Li-Fraumeni syndrome or Turcot syndrome may increase the risk of gliomas, including oligodendroglioma. However, these inherited conditions are more frequently associated with astrocytic or embryonal tumors and account for only a minority of oligodendroglioma cases. Exposure to ionizing radiation, particularly in childhood, is one of the few environmental risk factors with consistent evidence. Individuals treated with cranial radiation for prior malignancies or benign conditions (such as tinea capitis) may have an increased risk of developing gliomas later in life, including oligodendrogliomas. […] In summary, while molecular alterations define the tumor itself, the risk factors for developing oligodendroglioma are largely non-modifiable and not fully elucidated. Current research continues to explore potential genetic, epigenetic, and environmental contributors to its pathogenesis.